Thrombin generation testing in routine clinical practice: are we there yet?
- 21 August 2008
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 142 (6), 889-903
- https://doi.org/10.1111/j.1365-2141.2008.07267.x
Abstract
Thrombin is the central enzyme in the coagulation cascade. Estimation of an individual's potential to generate thrombin may correlate more closely with a hyper- or hypo-coagulable phenotype, compared to traditional coagulation tests. The possible correlation and recent technical advances in thrombin generation measurement has caused a significant interest in the method and the development of commercial assays. Several variations of the assay exist depending on the defect to be investigated. Fluorogenic thrombin generation assays have acceptable intra-laboratory variation but a higher inter-laboratory variation. Variation in preanalytical variables makes comparisons between studies difficult. Thrombin generation is highly variable between individuals and there are suggestions that this may allow individualized treatment based on global haemostatic response in patients with bleeding disorders or on anticoagulant therapy. In patients with thrombotic disorders it may be possible to identify those at higher risk of recurrent thrombosis. For both scenarios, however, data from large prospective studies are lacking or inconclusive and a good relationship between thrombin generation and phenotype remains to be established. Further standardization of the assay is needed before large multicentre studies can be conducted and until then thrombin generation in routine clinical practice is not yet a reality.Keywords
This publication has 109 references indexed in Scilit:
- Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemiaJournal of Thrombosis and Haemostasis, 2007
- In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilateThrombosis and Haemostasis, 2007
- Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombographyThrombosis and Haemostasis, 2007
- Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic StrokeStroke, 2006
- Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decisionHaemophilia, 2005
- Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and BThrombosis and Haemostasis, 2005
- The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formationThrombosis and Haemostasis, 2004
- Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole bloodThrombosis and Haemostasis, 2004
- Monitoring the bioavailability of FEIBA with a thrombin generation assayJournal of Thrombosis and Haemostasis, 2003
- Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasmaThrombosis and Haemostasis, 2003